2022 ABCAB Bioprocessing Symposium:
“Viral Vector Manufacturing”

On Behalf of Dr. Jay Stout, ABCAB Chair (President & Founder, Sage Biosolutions) and Dr. Sue Behrens, George B. and Joy Rathmann Professor in Bioprocessing and Director of KGI’s Amgen Bioprocessing Center:

You are cordially invited to attend the two-day event which includes a reception, industry guest speakers, and student research presentations related to viral vector manufacturing.

∙  Industry-Student Reception
Thursday, March 10, 2022
5:30 – 8:00 p.m.—Oasis KGI Commons Courtyard

∙ In-Person/Hybrid Symposium
Friday, March 11, 2022
8:00 a.m. – 5:00 p.m.—Bldg. 517, Room 165 (Founders Room)
(links to virtual viewing will be provided at a later date)

INDUSTRY INSIGHTS FEATURED SPEAKERS 

Dr. John Kerwin
Technical Head Gene Therapy Franchise, Resilience
High Throughput Process & Analytical Development (PAD) for Viral Vectors

Dr. John Moscariello
Executive Director Viral Vector and Gene Editing Process Development, Bristol Myers Squibb
Enabling cell therapies utilizing ex vivo gene delivery

Dr. Phillip Ramsey
Vice President, Technical Development, Sangamo Therapeutics
Navigating the Manufacturing and Supply Chain challenges in Commercializing Cell and Gene Therapy Products

AGENDA (subject to change)